YONDELIS (Janssen Products, LP)


Welcome to the PulseAid listing for the YONDELIS drug offered from Janssen Products, LP. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Products, LP
NON-PROPRIETARY NAME: Trabectedin
SUBSTANCE NAME: TRABECTEDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00


YONDELIS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionYONDELIS from Janssen Products, LP
LABELER NAME: Janssen Products, LP
DEA SCHEDULE:
ACTIVE STRENGTH: 0.05(mg/mL)
START MARKETING DATE: 2015-10-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59676-610_91873b39-8de1-422b-b643-ed5151c60416
PRODUCT NDC: 59676-610
APPLICATION NUMBER: NDA207953

Other TRABECTEDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Janssen Products, LPYONDELIS